| Rahul Mahendra Varman, MD | |
|
7710 Mercy Rd Ste 3000, Omaha, NE 68124-2350 | |
| (402) 932-1999 | |
| Not Available |
| Full Name | Rahul Mahendra Varman |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 7710 Mercy Rd Ste 3000, Omaha, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023539426 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | BP10061764 (Texas) | Secondary |
| 207Y00000X | Otolaryngology | 2022-00841 (North Carolina) | Secondary |
| 207Y00000X | Otolaryngology | 35787 (Nebraska) | Primary |
| Entity Name | University Of North Carolina At Chapel Hill |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780669200 PECOS PAC ID: 0648181156 Enrollment ID: O20031105000359 |
News Archive
Building on its reputation as a global technology leader in laser and light-based aesthetic systems, Cynosure, Inc. today announced that it has acquired the assets of the aesthetic laser business of HOYA ConBio, a wholly owned subsidiary of Japan-based HOYA Corporation, for $24.5 million in cash. HOYA ConBio is based in Fremont, California.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra, to include a two-dose schedule for infants and children 9 months through 23 months of age.
Equinox Surgical Solutions LLC today announced the launch of their new product, SutureAssist®, designed and developed by a minimally invasive, Board Certified, OB/GYN surgeon Dr. Warren Volker M.D., Ph.D. and his team to improve patient and surgical team safety. This proprietary device lets surgeons and scrub techs acquire, hand-off, dispose of and reload sutures with an efficient, one-handed motion resulting in significantly quicker wound closure and mitigation of both needle-stick risk to the surgical team and post-op needle management liability exposure.
Shire plc, the global specialty biopharmaceutical company, announces that the Food and Drug Administration (FDA), following a thorough administrative review of governing statutory and regulatory standards and public comments, has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rahul Mahendra Varman, MD 7261 Mercy Rd, Omaha, NE 68124-2311 Ph: () - | Rahul Mahendra Varman, MD 7710 Mercy Rd Ste 3000, Omaha, NE 68124-2350 Ph: (402) 932-1999 |
News Archive
Building on its reputation as a global technology leader in laser and light-based aesthetic systems, Cynosure, Inc. today announced that it has acquired the assets of the aesthetic laser business of HOYA ConBio, a wholly owned subsidiary of Japan-based HOYA Corporation, for $24.5 million in cash. HOYA ConBio is based in Fremont, California.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra, to include a two-dose schedule for infants and children 9 months through 23 months of age.
Equinox Surgical Solutions LLC today announced the launch of their new product, SutureAssist®, designed and developed by a minimally invasive, Board Certified, OB/GYN surgeon Dr. Warren Volker M.D., Ph.D. and his team to improve patient and surgical team safety. This proprietary device lets surgeons and scrub techs acquire, hand-off, dispose of and reload sutures with an efficient, one-handed motion resulting in significantly quicker wound closure and mitigation of both needle-stick risk to the surgical team and post-op needle management liability exposure.
Shire plc, the global specialty biopharmaceutical company, announces that the Food and Drug Administration (FDA), following a thorough administrative review of governing statutory and regulatory standards and public comments, has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
› Verified 7 days ago
Tyler Andrew Bliss, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 981225 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 316-208-9184 | |
Debora Goebel, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 720 N 129th St, Omaha, NE 68154 Phone: 402-397-0670 Fax: 402-397-0713 | |
Justin Oltman, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 981225 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-7005 Fax: 402-559-8940 | |
Anne Kristin Maxwell, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4014 Leavenworth St, Ent Clinic At Laurizten Outpatient Center, Omaha, NE 68105 Phone: 402-559-5208 | |
John W Pflug, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 16929 Frances St, Suite 201 Omaha Ear, Nose & Throat Clinic, Omaha, NE 68130 Phone: 402-758-5330 Fax: 402-758-5339 | |
James V Huerter Jr., MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 17030 Lakeside Hills Plz, Suite 204, Omaha, NE 68130 Phone: 402-758-5600 Fax: 402-758-5169 |